文献速递心血管CT

高敏肌钙蛋白时代心脏CT晚期碘增强在急性心脏症状患者中的作用

The role of cardiac CT with late iodine enhancement in patients with acute cardiac symptoms and troponin elevation in the era of high-sensitivity assays.
PubMed 文献 · Eur Radiol · 2026-10-15

前瞻性纳入191例急性胸痛、肌钙蛋白升高但无急性心肌梗死患者,行CCTA排除阻塞性冠心病,阴性者加做晚期碘增强和细胞外容积分数。CT改变了48%患者的工作诊断,与出院诊断一致性0.94,CT阴性者中期随访无MACE。

要点

  • CCTA阴性者中55% LIE/ECV阳性,可鉴别心肌炎、非阻塞性AMI、Takotsubo等病因
  • CT使48%患者的工作诊断发生改变,与出院诊断一致性高(0.94)
  • CCTA+LIE/ECV全阴性者中期随访无主要不良心血管事件

核心结论

  • 在急性症状、肌钙蛋白升高且无AMI的患者中,CCTA+LIE/ECV联合方案可对冠状动脉和心肌进行病因学评估,优化工作诊断,且结果阴性时预后良好。

研究设计与样本

  • 前瞻性研究,连续纳入2018年6月至2025年2月急性胸痛或等效症状、肌钙蛋白升高且无AMI诊断的患者,排除既往血运重建者,共191例(年龄70[55-79]岁,53%男性)。
  • 患者先行CCTA排除阻塞性CAD(狭窄≥50%),CCTA阴性者行LIE心肌组织表征,LIE阴性者进一步定量ECV。
  • 主要终点为CT对工作诊断的修改;次要终点为CT与标准诊疗后出院诊断的一致性,以及CT阴性患者的中期MACE。

关键影像表现/征象

  • CCTA在76/191(40%)患者中检出阻塞性CAD。
  • CCTA阴性者中LIE/ECV阳性58/106(55%),包括心肌炎32/106(30%)、非阻塞性CAD的AMI 8/106(8%)、Takotsubo 14/106(13%)、淀粉样变性3/106(3%)、扩张型心肌病1/106(1%)。

诊断标准与关键数值

  • CCTA以狭窄≥50%定义阻塞性CAD。
  • CT与出院诊断一致性为0.94(95%CI 0.89-0.97)。
  • CT阴性患者随访24[IQR 19-29]个月无MACE发生。

临床应用与阅片要点

  • 对急性胸痛、肌钙蛋白升高但不符合AMI标准的患者,可考虑CCTA+LIE/ECV方案快速进行病因诊断。
  • CCTA排除阻塞性CAD后,应关注LIE/ECV所提示的心肌炎、Takotsubo、非阻塞性AMI等病因。
  • CT全阴性者中期预后良好,可能减少额外下游检查。

局限性

  • 单中心前瞻性研究,样本量191例,结果需多中心验证。
  • 未设随机对照,CT对临床决策和下游检查的影响需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Diagnostic workup of patients with acute cardiac symptoms, troponin elevation, and no acute myocardial infarction (AMI) criteria is challenging. Cardiac CT angiography (CCTA) rules out obstructive coronary artery disease (CAD). Adding late iodine enhancement and extracellular volume fraction (CCTA + LIE/ECV) provides insights into myocardial injury. However, the impact on working diagnosis, agreement with discharge diagnosis, and mid-term safety of implementing CCTA + LIE/ECV in the emergency department remains uncertain.

MATERIALS AND METHODS: Prospective study on consecutive patients presenting, from June 2018 to February 2025, with acute chest pain or equivalents, elevated troponin, and no AMI diagnosis, excluding previously revascularized patients. Patients underwent CCTA to rule out obstructive CAD (≥ 50% stenosis). CCTA-negative patients underwent myocardial tissue characterization with LIE; if negative, ECV was quantified.

PRIMARY ENDPOINT: modification of working diagnosis by CT. Secondary endpoints: agreement between CT and discharge diagnoses after standard-of-care assessment; mid-term major adverse cardiovascular events (MACEs) in CT-negative patients.

RESULTS: Among 191 patients (age 70 [55-79] years; 53% men), CCTA identified obstructive CAD in 76/191 (40%). LIE/ECV were positive in 58/106 (55%) of CCTA-negative cases, revealing myocarditis in 32/106 (30%), AMI with non-obstructive CAD in 8/106 (8%), Takotsubo in 14/106 (13%), amyloidosis in 3/106 (3%), and dilated cardiomyopathy in 1/106 (1%). CT modified the working diagnosis in 91/191 (48%) patients. Agreement between CT and discharge diagnosis was 0.94 (95% CI 0.89-0.97). In patients with negative CCTA + LIE/ECV, no MACEs occurred after 24 [interquartile range, 19-29] months.

CONCLUSION: In patients with acute symptoms, elevated troponin, and no AMI, a protocol combining CCTA + LIE/ECV enables etiologic assessment of coronary and myocardial conditions, refines working diagnosis, and entails a favorable prognosis when negative.

KEY POINTS: Question Patients with acute cardiac symptoms, troponin elevation, and no evidence of acute myocardial infarction represent a diagnostic challenge: cardiac CT with late iodine enhancement may have diagnostic and prognostic implications. Findings CT angiography with late iodine enhancement provided a diagnosis in 75% of patients and modified the working diagnosis in 48%. In the 25% CT-negative patients, no adverse events occurred at mid-term follow-up. Clinical relevance A CT protocol including coronary artery evaluation and myocardial tissue characterization may provide a rapid etiological diagnosis in patients with acute symptoms and troponin elevation, potentially supporting earlier clinical decision-making and reducing the need for additional downstream testing.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Vignale D, Gambato G, Palmisano A, et al. The role of cardiac CT with late iodine enhancement in patients with acute cardiac symptoms and troponin elevation in the era of high-sensitivity assays. Eur Radiol. 2026. PMID: 42878809. doi:10.1007/s00330-026-12967-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。